Retaglutide is a innovative GLP-1 receptor agonist currently under investigation for the management of type 2 diabetes. This therapy works by enhancing the effects of glucagon-like peptide-1 (GLP-1), a naturally https://carlyplth230167.get-blogging.com/39489243/trelaglutide-exploring-a-new-option-for-chronic-diseases